The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 285.00
Bid: 280.00
Ask: 290.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 285.00
TRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Total Voting Rights

1 Feb 2019 13:17

RNS Number : 8637O
Triad Group Plc
01 February 2019
 

Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84

 

 

 

Triad Group Plc

("Triad" or "the Company")

 

Director/PDMR Shareholding

 

Triad Group Plc, the UK-based IT systems, consulting and resourcing company, was notified on 31 January 2019 that Adrian Leer, Managing Director, has exercised 150,000 options over Ordinary shares of 1p each ("Ordinary Shares"), granted pursuant to the Company's 2008 Share Option Scheme. 50,000 options have been exercised at an exercise price of 13.5 pence per Ordinary share, and 100,000 options at an exercise price of 11 pence per Ordinary Share.

 

Mr Leer currently has no intention of selling these shares.

 

These 150,000 Ordinary Shares will be admitted to trading pursuant to an existing block listing granted to the Company by London Stock Exchange plc and will rank pari passu with existing Ordinary Shares.

 

Following the issue of these Ordinary Shares, the total number of voting rights in Triad is 15,968,979, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of Triad under the FCA's Disclosure and Transparency rules.

 

Contacts:

 

Triad Group Plc

Nick Burrows - Finance Director

01908 278 450

 

Arden Partners

Tom Price

Benjamin Cryer

020 7614 5932

 

 

 

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Adrian Leer

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Triad Group plc

b)

 

LEI

 

 

213800MDNBFVEQEN1G84

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

 

ISIN : GB0009035741

 

b)

 

Nature of the transaction

 

Exercise of Options

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

£0.135

50,000

£0.11

100,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

150,000

 

 

£0.118

 

e)

 

Date of the transaction

 

 

31 January 2019

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLFLFBKLFBBBV
Date   Source Headline
1st May 20245:00 pmRNSHolding(s) in Company
1st May 20245:00 pmRNSTotal Voting Rights
14th Mar 20243:00 pmRNSBlock listing Interim Review
7th Mar 202411:00 amRNSTrading Statement
29th Feb 20242:00 pmRNSTotal Voting Rights
3rd Jan 202411:43 amRNSTotal Voting Rights
21st Dec 20231:00 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSHalf-year Report
14th Sep 202312:00 pmRNSBlock listing Six Monthly Return
27th Jul 20231:30 pmRNSResult of AGM
25th Jul 20233:00 pmRNSTotal Voting Rights
4th Jul 20236:00 pmRNSCorrection - Dividend Declaration
4th Jul 20233:00 pmRNSDividend Declaration
4th Jul 20233:00 pmRNSNotice of AGM
3rd Jul 202312:00 pmRNSDirector/PDMR Shareholding
30th Jun 20231:00 pmRNSDirector/PDMR Shareholding
28th Jun 20231:30 pmRNSDirectorate Change
28th Jun 20231:30 pmRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector dealings
12th Jun 20237:00 amRNSAnnual Financial Report
1st Jun 20237:00 amRNSDirectorate Change
9th May 20234:30 pmRNSDirector/PDMR Shareholding
31st Mar 202310:30 amRNSChange of Broker
14th Mar 20233:00 pmRNSBlock listing Review
28th Feb 202311:00 amRNSHolding(s) in Company
15th Feb 202312:00 pmRNSHolding(s) in Company
18th Jan 20234:40 pmRNSSecond Price Monitoring Extn
18th Jan 20234:35 pmRNSPrice Monitoring Extension
18th Jan 20237:00 amRNSTrading Statement
22nd Dec 20229:00 amRNSTotal Voting Rights
1st Dec 20227:00 amRNSHalf-year Report
10th Nov 202212:00 pmRNSTotal Voting Rights
14th Sep 202212:00 pmRNSBlock Listing Six Monthly Review
12th Sep 202212:00 pmRNSHolding(s) in Company
8th Sep 20224:30 pmRNSDirector/PDMR Shareholding
21st Jul 202210:00 amRNSResult of AGM
15th Jul 20229:00 amRNSTotal Voting Rights
11th Jul 20225:00 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSNotice of AGM
28th Jun 20227:00 amRNSDividend Declaration
9th Jun 20225:00 pmRNSTotal Voting Rights
7th Jun 202212:30 pmRNSHolding(s) in Company
1st Jun 20223:00 pmRNSHolding(s) in Company
31st May 20224:30 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSDirector/PDMR Shareholding
30th May 20223:00 pmRNSHolding(s) in Company
26th May 20227:00 amRNSAnnual Financial Report
12th Apr 20224:30 pmRNSHolding(s) in Company
31st Mar 20224:30 pmRNSGrant of Restrictive Share Units

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.